Location History:
- Atlanta, GA (US) (2018)
- Norcross, GA (US) (2016 - 2020)
Company Filing History:
Years Active: 2016-2020
Title: Ray J Dingledine: Innovator in Prostaglandin Receptor Research
Introduction
Ray J Dingledine is a prominent inventor based in Norcross, GA (US). He has made significant contributions to the field of pharmacology, particularly in the development of Prostaglandin receptor EP2 antagonists. With a total of 4 patents to his name, Dingledine's work has the potential to impact various medical conditions.
Latest Patents
Dingledine's latest patents focus on Prostaglandin receptor EP2 antagonists, derivatives, compositions, and their related uses. The disclosures detail methods for treating or preventing conditions where EP2 receptor activation plays a physiological role. These conditions include brain injury, inflammatory diseases, neuroinflammation after seizures, pain, endometriosis, cancer, rheumatoid arthritis, skin inflammation, vascular inflammation, colitis, and neurological disorders. The pharmaceutical compositions developed by Dingledine aim to provide therapeutic benefits to subjects in need.
Career Highlights
Ray J Dingledine is affiliated with Emory University, where he conducts his research and development work. His innovative approach to pharmacology has garnered attention in the scientific community, leading to advancements in treatment methodologies.
Collaborations
Dingledine has collaborated with notable colleagues such as Jianxiong Jiang and Thota Ganesh. These partnerships have further enriched his research endeavors and contributed to the success of his projects.
Conclusion
Ray J Dingledine's contributions to the field of pharmacology, particularly through his patents on Prostaglandin receptor EP2 antagonists, highlight his role as an influential inventor. His work continues to pave the way for new treatment options for various medical conditions.